These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
426 related items for PubMed ID: 20719301
1. Intravitreal ranibizumab for choroidal neovascularization in angioid streaks. Mimoun G, Tilleul J, Leys A, Coscas G, Soubrane G, Souied EH. Am J Ophthalmol; 2010 Nov; 150(5):692-700.e1. PubMed ID: 20719301 [Abstract] [Full Text] [Related]
2. INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up. Tilleul J, Mimoun G, Querques G, Puche N, Zerbib J, Lalloum F, Srour M, Souied EH. Retina; 2016 Mar; 36(3):483-91. PubMed ID: 26355947 [Abstract] [Full Text] [Related]
3. Intravitreal ranibizumab treatment of macular choroidal neovascularization secondary to angioid streaks: one-year results of a prospective study. Ladas ID, Kotsolis AI, Ladas DS, Niskopoulou M, Georgalas I, Papakonstantinou D, Rouvas AA. Retina; 2010 Sep; 30(8):1185-9. PubMed ID: 20539257 [Abstract] [Full Text] [Related]
4. Combination treatment with intravitreal injection of ranibizumab and reduced fluence photodynamic therapy for choroidal neovascularization secondary to angioid streaks: preliminary clinical results of 12-month follow-up. Artunay O, Yuzbasioglu E, Rasier R, Sengul A, Senel A, Bahcecioglu H. Retina; 2011 Sep; 31(7):1279-86. PubMed ID: 21394063 [Abstract] [Full Text] [Related]
5. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks. Sawa M, Gomi F, Tsujikawa M, Sakaguchi H, Tano Y. Am J Ophthalmol; 2009 Oct; 148(4):584-590.e2. PubMed ID: 19541288 [Abstract] [Full Text] [Related]
6. Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks: one year of follow-up. El Matri L, Kort F, Bouraoui R, Karim B, Chebil A, Chaker N. Acta Ophthalmol; 2011 Nov; 89(7):641-6. PubMed ID: 21155980 [Abstract] [Full Text] [Related]
7. Clinical course of choroidal neovascularization secondary to angioid streaks treated with intravitreal bevacizumab. Teixeira A, Mattos T, Velletri R, Teixeira R, Freire J, Moares N, Bonomo PP. Ophthalmic Surg Lasers Imaging; 2010 Nov; 41(5):546-9. PubMed ID: 20795575 [Abstract] [Full Text] [Related]
9. Angioid streak-related choroidal neovascularization treated by intravitreal ranibizumab. Vadalà M, Pece A, Cipolla S, Monteleone C, Ricci F, Boscia F, Cillino S. Retina; 2010 Jun; 30(6):903-7. PubMed ID: 20531143 [Abstract] [Full Text] [Related]
10. Intravitreal ranibizumab for the primary treatment of choroidal neovascularization secondary to pathologic myopia. Lai TY, Chan WM, Liu DT, Lam DS. Retina; 2009 Jun; 29(6):750-6. PubMed ID: 19357555 [Abstract] [Full Text] [Related]
11. Monthly ranibizumab for choroidal neovascularizations secondary to angioid streaks in pseudoxanthoma elasticum: a one-year prospective study. Finger RP, Charbel Issa P, Hendig D, Scholl HP, Holz FG. Am J Ophthalmol; 2011 Oct; 152(4):695-703. PubMed ID: 21704964 [Abstract] [Full Text] [Related]
12. Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia. Lalloum F, Souied EH, Bastuji-Garin S, Puche N, Querques G, Glacet-Bernard A, Coscas G, Soubrane G, Leveziel N. Retina; 2010 Mar; 30(3):399-406. PubMed ID: 20038864 [Abstract] [Full Text] [Related]
13. Selective occlusion of subfoveal choroidal neovascularization in angioid streaks by using a new technique of ingrowth site treatment. Costa RA, Calucci D, Cardillo JA, Farah ME. Ophthalmology; 2003 Jun; 110(6):1192-203. PubMed ID: 12799247 [Abstract] [Full Text] [Related]
14. [Intravitreal ranibizumab for choroidal neovascularization secondary to pathological myopia: 12-month results]. Cornut PL, Poli M, Feldman A, El Chehab H, Swalduz B, Burillon C, Denis P. J Fr Ophtalmol; 2010 May; 33(5):327-33. PubMed ID: 20452098 [Abstract] [Full Text] [Related]
15. Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in patients with angioid streaks. Wiegand TW, Rogers AH, McCabe F, Reichel E, Duker JS. Br J Ophthalmol; 2009 Jan; 93(1):47-51. PubMed ID: 18971238 [Abstract] [Full Text] [Related]
16. Intravitreal bevacizumab for nonsubfoveal choroidal neovascularization associated with angioid streaks. Battaglia Parodi M, Iacono P, La Spina C, Berchicci L, Scotti F, Leys A, Introini U, Bandello F. Am J Ophthalmol; 2014 Feb; 157(2):374-377.e2. PubMed ID: 24211865 [Abstract] [Full Text] [Related]
17. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ, Puliafito CA, Davis JL, Flynn HW, Esquiabro M. Am J Ophthalmol; 2007 Apr; 143(4):566-83. PubMed ID: 17386270 [Abstract] [Full Text] [Related]
18. Switching from ranibizumab to aflibercept in choroidal neovascularization secondary to angioid streaks. Sekfali R, Mimoun G, Cohen SY, Querques G, Bandello F, Sacconi R, Souied EH, Capuano V. Eur J Ophthalmol; 2020 May; 30(3):550-556. PubMed ID: 30880436 [Abstract] [Full Text] [Related]
19. Microperimetric retinal changes in myopic choroidal neovascularization treated with intravitreal ranibizumab. Varano M, Tedeschi M, Oddone F, Perillo L, Coppè AM, Parravano M. Retina; 2010 Mar; 30(3):413-7. PubMed ID: 20010453 [Abstract] [Full Text] [Related]
20. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Kaiser PK, Blodi BA, Shapiro H, Acharya NR, MARINA Study Group. Ophthalmology; 2007 Oct; 114(10):1868-75. PubMed ID: 17628683 [Abstract] [Full Text] [Related] Page: [Next] [New Search]